Apeiron Capital Investment Corp.
DelistedCIK 1849011fmd_06RDFJW91AP5BY3A78NRDQ70GTManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2021 to Mar 31, 2023, 9 periods
| Line item | FY2021 | FY2022 |
|---|---|---|
| Realized investment gains (losses) | 0 | – |
| Operating income | (0) | (1) |
| Interest and investment income | 0 | 2 |
| Other non-operating income (expense) | 1 | 8 |
| Income before taxes | 0 | 7 |
| Income tax expense | 0 | 1 |
| Net income from continuing operations | 0 | 7 |
| Net income | 0 | 7 |